However, heterogenous results about the ability to distinguish PC from benign lesions using GPC1+ EVs were obtained by Frampton et al. and Lucien et al., highlighting that further studies are needed to validate GPC-1 as a diagnostic biomarker of PC [166,167]. The gene discussed is GPC1; the disease is pachyonychia congenita.